Literature DB >> 24421518

ISMP Adverse Drug Reactions.

.   

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936; e-mail: mmancano@temple.edu). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

Year:  2013        PMID: 24421518      PMCID: PMC3839526          DOI: 10.1310/hpj4870-542

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  1 in total

1.  Low molecular weight heparin-induced skin necrosis: a case report.

Authors:  Anastasios Katsourakis; George Noussios; George Kapoutsis; Efthimios Chatzitheoklitos
Journal:  Case Rep Med       Date:  2011-05-30
  1 in total
  2 in total

1.  Comment on Tapentadol and Serotonin Syndrome.

Authors:  Michael E Mullins; William H Dribben
Journal:  Hosp Pharm       Date:  2017-04

2.  Spontaneously reported adverse drug events related to tapentadol and oxycodone/naloxone in Australia.

Authors:  Carmen Abeyaratne; Samanta Lalic; J Simon Bell; Jenni Ilomäki
Journal:  Ther Adv Drug Saf       Date:  2018-03-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.